1、MARKET REVIEW EUROPEAN GENERIC MEDICINE MARKETSPOLICY OVERVIEW2023 2023 Market Review|European Generic Medicines Market Policy Overview|Authors:Maja Graf,Associate Director Policy&Market Access-Alejandro Pacheco,Market Access Officer.Credit photos:Fotolia|Graphic Design:Jos Antonio Garca Snchez|Issu

2、ed in June 2023 Belgium|Medicines for Europe Generic Medicines Group|Rue dArlon 50 B-1000 Brussels BelgiumThe 2023 Market Review European Generic Medicine Markets Policy Overview is the property of the Generic Medicines Group,a sector group of Medicines for Europe.The 2023 Market Review European Gen

3、eric Medicine Markets Policy Overview is intended as a reference tool only.All information obtained by the Generic Medicines Group from various sources is as current and accurate as possible.However,due to human or mechanical errors and to constant changes in the rules and regulations in the studied

4、 markets,the Generic Medicines Group cannot guarantee the accuracy,adequacy,or completeness of any information,andcannot be held responsible for any errors or omissions,or damages arising from the use thereof.Country National Association/Member Company Contact PersonACKNOWLEDGEMENTS 2Austria OeGV Wo

5、lfgang AndielBelgium Medaxes Wim VermaetBulgaria Bulgarian generic pharmaceutical association Evgeni TassovskiCroatia Croatian Employers Association Pharmaceutical Industry Association Milka KosanovicRepublic of Cyprus Sandoz Elena ArmelidouCzech Republic CAFF Jana BenovDenmark IGL Peter JrgensenEst

6、onia Sandoz Roland LepikFinland Finnish generic pharmaceutical association Heikki BothasFrance GEMME Sebastien Trinquard Germany Pro Generika Gloria von SchorlemerGreece Panhellenic Union of Pharmaceutical Industry Marc OllandezosHungary MAGYOSZ/Generikus Egyesulet Zsuzsanna Illes/Dora OrosIreland M